These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15026286)

  • 21. Clinical implications of measurement of serum nuclear matrix protein levels in patients with liver disease.
    Shimizu Y; Nakano I; Katano Y; Shimizu H; Fukuda Y
    Hepatogastroenterology; 2005; 52(66):1809-13. PubMed ID: 16334782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymerized human serum albumin binding activity of sera from patients with various liver disorders (studied by a passive hemagglutination test).
    Claustres M; Szauto I; Magnan de Bornier B
    Biomed Pharmacother; 1985; 39(2):100-2. PubMed ID: 2990588
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum bile acid levels in liver disease: is there a clinical application?
    Tabibian N
    South Med J; 1988 Feb; 81(2):281-2. PubMed ID: 3340883
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic viral hepatitis--one of the most important problems of current medicine].
    Serov VV; Aprosina ZG; Krel' PE; Ignatova TM; Sekamova SM; Tanashchuk EL; Bushueva NV; Il'iankova AA; Drozdova AS
    Arkh Patol; 2004; 66(6):6-11. PubMed ID: 15648159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipids and lipoproteins in liver diseases].
    Vogt N; Greiner M; Wienbeck M; Dölle W; Englhardt A
    Verh Dtsch Ges Inn Med; 1972; 78():1330-2. PubMed ID: 4665536
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of urinary collagen in chronic liver diseases].
    Gichev IuP; Peskisheva SF
    Ter Arkh; 1980; 52(11):63-6. PubMed ID: 7193359
    [No Abstract]   [Full Text] [Related]  

  • 27. [Etiology of hepatic cirrhosis and its outcome in patients observed in a multidisciplinary hospital].
    Fisun AIa; Beliakin SA; Bobrov AN; Pliusnin SV; Khazanov AI
    Voen Med Zh; 2009 Apr; 330(4):17-23. PubMed ID: 19537101
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of ion-exchange chromatography of amino acids in acute and chronic liver diseases].
    Mironova IS; Semendiaeva ME; Spektor EB
    Sov Med; 1973 Jun; 36(6):111-5. PubMed ID: 4747408
    [No Abstract]   [Full Text] [Related]  

  • 29. Hyperadiponectinemia in alcoholic liver disease: friend or foe?
    Adachi M; Ishii H
    J Gastroenterol Hepatol; 2009 Apr; 24(4):507-8. PubMed ID: 19368631
    [No Abstract]   [Full Text] [Related]  

  • 30. Protein C in patients with alcoholic cirrhosis and other liver diseases.
    Bell H; Odegaard OR; Andersson T; Raknerud N
    J Hepatol; 1992 Mar; 14(2-3):163-7. PubMed ID: 1500680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Urinary free L-fucose (UFC) and urinary sulfated bile acids (U-SBA)].
    Mashige F
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():774-8. PubMed ID: 16149638
    [No Abstract]   [Full Text] [Related]  

  • 32. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
    Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
    Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of hepatitis C virus among patients with liver disease in the Republic of Yemen.
    Al-Moslih MI; Al-Huraibi MA
    East Mediterr Health J; 2001; 7(4-5):771-8. PubMed ID: 15332778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemostasis and liver disease.
    Mannucci PM; Mari D
    Haematologica; 1981 Apr; 66(2):233-48. PubMed ID: 6792002
    [No Abstract]   [Full Text] [Related]  

  • 35. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?
    Thuluvath PJ; Krok KL
    Am J Gastroenterol; 2006 Jul; 101(7):1497-9. PubMed ID: 16863552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of the uranyl acetate test in the diagnosis of liver diseases].
    Fischer P; Reinelt D
    Z Gesamte Inn Med; 1968 Jun; 23(12):Suppl:177-9. PubMed ID: 5687435
    [No Abstract]   [Full Text] [Related]  

  • 37. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening for hepatocellular carcinoma].
    Leone N; Rizzetto M
    Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver cirrhosis, other liver diseases, pancreatitis and subsequent cancer: record linkage study.
    Goldacre MJ; Wotton CJ; Yeates D; Seagroatt V; Collier J
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):384-92. PubMed ID: 18403939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of hepatitis B vaccination to induce either humoral or cellular immune response after liver transplantation for hepatitis B related cirrhosis.
    Merli M; Nicolini G; Attili FA; Accapezzato D; Barnaba V; Ferretti G; Lilli D; Rivanera D; Rossi M; Novelli G; Berloco P
    J Hepatol; 2005 Dec; 43(6):1089-90; author reply 1090. PubMed ID: 16253382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.